{"id":7545,"date":"2022-06-07T08:23:51","date_gmt":"2022-06-07T08:23:51","guid":{"rendered":"https:\/\/zaratechs.com\/?p=7545"},"modified":"2022-06-07T08:23:51","modified_gmt":"2022-06-07T08:23:51","slug":"clot-management-devices-market-share-2021-industry-size-growth-trends-and-forecast-2026","status":"publish","type":"post","link":"https:\/\/zaratechs.com\/clot-management-devices-market-share-2021-industry-size-growth-trends-and-forecast-2026\/","title":{"rendered":"Clot Management Devices\u00a0Market Share 2021 | Industry Size, Growth, Trends And Forecast 2026"},"content":{"rendered":"\n

According to IMARC Group\u2019s latest report, titled \u201cClot Management Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,\u201d the global clot management devices market exhibited moderate growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of 5.1% during 2021-2026.<\/p>\n\n\n\n

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.<\/p>\n\n\n\n

A blood clot blocks the blood supply to certain parts of the body and can cause severe damage in the long run. However, it can be treated using different clot management devices, such as embolectomy balloon catheters, neurovascular embolectomy devices, catheter-directed thrombolysis (CDT), percutaneous thrombectomy devices and inferior vena cava filters (IVCF). These devices further help in preventing ischemic strokes, severe leg pain and heart attacks.<\/p>\n\n\n\n

Request Free Sample Report:<\/strong> https:\/\/www.imarcgroup.com\/clot-management-devices-market\/requestsample<\/a><\/p>\n\n\n\n

Market Trends<\/strong><\/p>\n\n\n\n

The rising prevalence of cardiovascular diseases (CVDs), along with the growing number of smokers, is increasing the risk of blood clots among individuals. This represents one of the key factors bolstering the clot management devices market growth. Additionally, the escalating demand for minimally invasive (MI) surgeries over open surgeries, is further impelling the market growth. Other than this, some of the leading players in the industry are focusing on introducing technological advancements, which are expected to drive the market in the upcoming years. For instance, Penumbra, Inc., a US-based healthcare company, launched Reperfusion Catheters ACE68, which is a large-bore aspiration catheter designed to navigate tortuous vessels to facilitate extraction of clot quickly.<\/p>\n\n\n\n

Ask Analyst and Browse Full Report with TOC & List of Figure:<\/strong> https:\/\/www.imarcgroup.com\/clot-management-devices-market<\/a><\/p>\n\n\n\n

List of Key Companies Covered in this Market Report:<\/strong><\/p>\n\n\n\n